Eledon
2 known investors
Eledon Pharmaceuticals is a clinical-stage biotechnology company developing immunology-based therapies, with a focus on protecting transplanted organs from rejection and treating autoimmune and neurodegenerative diseases including ALS. The company's lead candidate is tegoprubart, an anti-CD40L antibody.
Founders & leadership
SP
Steven PerrinPresident and Chief Scientific Officer
Investors Β· 2
Frequently asked questions
- What does Eledon do?
- Eledon Pharmaceuticals is a clinical-stage biotechnology company developing immunology-based therapies, with a focus on protecting transplanted organs from rejection and treating autoimmune and neurodegenerative diseases including ALS. The company's lead candidate is tegoprubart, an anti-CD40L antibody.
- Who are Eledon's investors?
- Eledon's investors include JDRF T1D Fund, Newpath Partners.